ArticleOncotarget2016

Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation.

Jung Wook Huh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.